Search Results - "Therapeutic advances in endocrinology and metabolism"

GLP-1 receptor agonists: an updated review of head-to-head clinical studies by Trujillo, Jennifer M., Nuffer, Wesley, Smith, Brooke A.

“…Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and…”
Get full text

Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always by Raghav, Alok, Khan, Zeeshan Ahmad, Labala, Rajendra Kumar, Ahmad, Jamal, Noor, Saba, Mishra, Brijesh Kumar

“…Diabetic foot complications are the most common occurring problems throughout the globe, resulting in devastating economic crises for the patients, families…”
Get full text

Reduced physical activity in young and older adults: metabolic and musculoskeletal implications by Bowden Davies, Kelly A., Pickles, Samuel, Sprung, Victoria S., Kemp, Graham J., Alam, Uazman, Moore, Daniel R., Tahrani, Abd A., Cuthbertson, Daniel J.

“…Background: Although the health benefits of regular physical activity and exercise are well established and have been incorporated into national public health…”
Get full text

MAFLD: a multisystem disease by Pipitone, Rosaria Maria, Ciccioli, Carlo, Infantino, Giuseppe, La Mantia, Claudia, Parisi, Stefanie, Tulone, Adele, Pennisi, Grazia, Grimaudo, Stefania, Petta, Salvatore

“…Nonalcoholic fatty liver disease (NAFLD), affecting about 25% of general population and more than 50% of dysmetabolic patients, is an emerging cause of chronic…”
Get full text

The role of thyroid hormone in metabolism and metabolic syndrome by Teixeira, Patrícia de Fátima dos Santos, dos Santos, Patrícia Borges, Pazos-Moura, Carmen Cabanelas

“…Metabolic syndrome (MetS) and thyroid dysfunction are common in clinical practice. The objectives of this review are to discuss some proposed mechanisms by…”
Get full text

Antidiabetic phytoconstituents and their mode of action on metabolic pathways by Bharti, Sudhanshu Kumar, Krishnan, Supriya, Kumar, Ashwini, Kumar, Awanish

“…Diabetes Mellitus, characterized by persistent hyperglycaemia, is a heterogeneous group of disorders of multiple aetiologies. It affects the human body at…”
Get full text

Should metformin remain the first-line therapy for treatment of type 2 diabetes? by Baker, Chelsea, Retzik-Stahr, Cimmaron, Singh, Vatsala, Plomondon, Renee, Anderson, Victoria, Rasouli, Neda

“…Metformin is a biguanide that is used as first-line treatment of type 2 diabetes mellitus and is effective as monotherapy and in combination with other…”
Get full text

Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia by Khunti, Sachin, Khunti, Kamlesh, Seidu, Samuel

“…Early glycaemic control leads to better outcomes, including a reduction in long-term macrovascular and microvascular complications. Despite good-quality…”
Get full text

GLP-1 receptor agonists: a review of head-to-head clinical studies by Trujillo, Jennifer M., Nuffer, Wesley, Ellis, Samuel L.

“…Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are attractive options for the treatment of type 2 diabetes (T2D) because they effectively lower A1C and…”
Get full text

Diabetic cardiomyopathy: prevalence, determinants and potential treatments by Gulsin, Gaurav S., Athithan, Lavanya, McCann, Gerry P.

“…The prevalence of type 2 diabetes (T2D) has reached a pandemic scale. These patients are at a substantially elevated risk of developing cardiovascular disease,…”
Get full text

Review of vancomycin-induced renal toxicity: an update by Bamgbola, Oluwatoyin

“…In recent times the use of larger doses of vancomycin aimed at curbing the increasing incidence of resistant strains of Staphylococcus aureus has led to a…”
Get full text

Adult obesity complications: challenges and clinical impact by Ansari, Saleem, Haboubi, Hasan, Haboubi, Nadim

“…The complications associated with adult obesity are overwhelming national healthcare systems. No country has yet implemented a successful population-level…”
Get full text

Role of inflammation in diabetic cardiomyopathy by Ramesh, Pranav, Yeo, Jian L., Brady, Emer M., McCann, Gerry P.

“…The prevalence of type 2 diabetes (T2D) has reached a pandemic scale. Systemic chronic inflammation dominates the diabetes pathophysiology and has been…”
Get full text

A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome by Abdalla, Mohammed Altigani, Deshmukh, Harshal, Atkin, Stephen, Sathyapalan, Thozhukat

“…Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age. Metabolic sequelae associated with PCOS range from insulin…”
Get full text

The obesity of bone by Greco, Emanuela A., Lenzi, Andrea, Migliaccio, Silvia

“…During the last decades, obesity and osteoporosis have become important global health problems, and the belief that obesity is protective against osteoporosis…”
Get full text

Modern pharmacological treatment of obese patients by May, Marcus, Schindler, Christoph, Engeli, Stefan

“…There are many angles to consider in drug treatment of obese patients. On the one hand, some specific weight loss drugs are available, on the other, several…”
Get full text

Association between air pollution and type 2 diabetes: an updated review of the literature by Li, Yongze, Xu, Lu, Shan, Zhongyan, Teng, Weiping, Han, Cheng

“…Air pollution and type 2 diabetes mellitus (T2DM) are critical public health issues worldwide. A large number of epidemiological studies have highlighted the…”
Get full text

Current best practice in the management of patients after pituitary surgery by Prete, Alessandro, Corsello, Salvatore Maria, Salvatori, Roberto

“…Sellar and parasellar masses are a common finding, and most of them are treated surgically via transsphenoidal approach. This type of surgery has…”
Get full text

Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications by Alharbi, Saleh Hadi

“…Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as promising therapeutic agents with potent anti-inflammatory properties and diverse clinical…”
Get full text

Effects of metformin in obesity treatment in different populations: a meta-analysis by Pu, Ruiyang, Shi, Dian, Gan, Ting, Ren, Xiaoyu, Ba, Yupei, Huo, Yanbei, Bai, Yana, Zheng, Tongzhang, Cheng, Ning

“…Objective: Some studies have shown that metformin can reduce body weight. However, metformin has not been officially approved as a medicine for weight loss…”
Get full text